baber/WOPTO huggingface dataset:
Patent EA-003425-B1 (EA)
Title: Plants with modified growth
Inventor: MURRAY JAMES AUGUST HENRY
IPC: C12N5/10
Filed: 1998-03-24
Abstract: 1. Chimeric gene comprising the following operably linked DNA fragments: a) a plant expressible promoter region; b) a transcribed DNA region, containing nucleotide sequence encoding cell-division controlling plant protein, in particular, plant D-type cyclin capable of binding or phosphorylating an Rb-like protein in cell plant, selected from the nucleotide sequence of EMBL Accession No. X83369 from the nucleotide position 104 to the nucleotide position 1108, encoding Arabidopsis thaliana CYCD1, from the nucleotide sequence of EMBL Accession No. X83370 from the nucleotide position 195 to the nucleotide position 1346, encoding Arabidopsis thaliana CYCD3, from the nucleotide sequence of SEQ ID No. 1 from nucleotide position 182 to nucleotide position 1243, encoding Nicotiana tabacum CYCD2; 1, from the nucleotide sequence of SEQ ID No. 2 from nucleotide position 181 to nucleotide position 1299, encoding Nicotiana tabacum CYCD3; 1,from the nucleotide sequence of SEQ ID No. 3 from nucleotide position 198 to nucleotide position 1298, encoding Nicotiana tabacum CYCD3; 2, from the nucleotide sequence of SEQ ID No. 4 from nucleotide position 165 to nucleotide position 1109, encoding Helianthus tuberosus CYCD1; 1, the nucleotide sequence of SEQ ID No. 5 from nucleotide position 48 to nucleotide position 1118, encoding Helianthus tuberosus CYCD3;1, from the nucleotide sequence of SEQ ID No. 21 from nucleotide position 316 to nucleotide position 1389, encoding Zea mays CYCD2, or genetically degenerated, variants of said nucleotide sequences, and c) a 3' end formation and polyadenylation signal functional in plant cells. 2. A process to obtain a plant with altered growth characteristics or altered architecture, said process comprising the altering the concentration or functional activity of a cell-division controlling protein, in particular D-type cyclin, capable of binding or phosphorylating an Rb-like protein in plant cells , by providing by expression of chimeric gene, characterized in claim 1, in said plant's cells.
Patent EA-003181-B1 (EA)
Title: Chemokine receptor antagonist and cyclosporin in combined therapy
Inventor: GRONE HERMANN-JOSEPH
IPC: A61K/
Filed: 1999-09-16
Abstract: 1. Use of a chemokine receptor antagonist in combination with a cyclosporin to produce a pharmaceutical composition for treating or preventing the rejection of tranplanted organs, tissues or cells. 2. The use according to claim 1, wherein the chemokine receptor antagonist and the cyclosporin are used simultaneously, separately or sequentially. 3. The use according to any preceding claim, wherein the chemokine receptor antagonist is an amino-terminally truncated chemokine. 4. The use according to claims 1 or 2, wherein the chemokine receptor antagonist is an amino-terminally extended RANTES. 5. The use according to claims 1 or 2, wherein the chemokine receptor antagonist is Met-RANTES. 6. The use according to any preceding claim, wherein the cyclosporin is selected among cyclosporin A as well as metabolites or synthetic analogues thereof. 7. The use according to any preceding claim, wherein the cyclosporin is cyclosporin A. 8. The use according to any preceding claim, for treating or preventing renal allograft transplantation. 9. Pharmaceutical composition containing a chemokine receptor antagonist and a cyclosporin, in the presence of one or more pharmaceutically acceptable excipients, for treating or preventing the rejection of transplanted organs, tissues or cells. 10. Pharmaceutical composition containing a chemokine receptor antagonist and a cyclosporin, in the presence of one or more pharmaceutically acceptable excipients, for the simultaneous, separate or sequential use of its active ingredients in treating or preventing the rejection of transplanted organs, tissues or cells. 11. The pharmaceutical composition according to claim 9 or 10, wherein the chemokine receptor antagonist is an amino-terminally truncated chemokine. 12. The pharmaceutical composition according to claims 9 or 10, wherein the chemokine receptor antagonist is an amino-terminally extended RANTES. 13. The pharmaceutical composition according to claims 9 or 10, wherein the chemokine receptor antagonist is Met-RANTES. 14. The pharmaceutical composition according to any of claims 9 to 13, wherein the cyclosporin is selected among cyclosporin A as well as metabolites or synthetic analogues thereof. 15. The pharmaceutical composition according to any of claims 10 to 14, wherein the cyclosporin is cyclosporin A. 16. The pharmaceutical composition according to any of claims 9 to 15, for treating or preventing renal allograft transplantation.
Patent EA-005408-B1 (EA)
Title: Tartrate salt of thiazolidinedione derivatives
Inventor: CRAIG ANDREW SIMON
IPC: C07D417/12
Filed: 2001-08-03
Abstract: The present invention relates to a novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione DL-Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
Patent EA-013878-B1 (EA)
Title: Ligands that have binding specificity for egfr and/or vegf and methods of use therefor
Inventor: IGNATOVICH OLGA
IPC: A61K39/395
Filed: 2006-12-05
Abstract: Disclosed are ligands that have binding specificity for vascular endothelial growth factor (VEGF), for epidermal growth factor receptor (EGFR), or for VEGF and EGFR. Also disclosed are methods of using these ligands. In particular, the use of these ligands for cancer therapy is described.
Patent EA-014120-B1 (EA)
Title: Method for defining element content and/or mineral content
Inventor: VON ALFTHAN CHRISTIAN
IPC: G01N23/223
Filed: 2006-12-19
Abstract: The invention relates to a method for defining particle and/or mineral content in real time in a mineral separation process from finely divided particle material flowing either in solid or slurry-like form, so that from the particle material, there is extracted a representative sample, which sample is then subjected to grain size analysis, on the basis of which there is calculated the element and/or mineral content of the particle material.
Patent EA-016650-B1 (EA)
Title: Process for carbonyl asymmetric alkylation
Inventor: ALBERT MARTIN
IPC: C07C215/30
Filed: 2007-01-22
Abstract: This invention relates to processes and intermediates for the stereoselective alkylation of carbonyl groups. The invention in particular allows the stereoselective preparation of the antidepressant drug escitalopram. It has been found that boric or boronic acid derivatives are useful bridging elements for the attachment of a chiral group to a compound containing a carbonyl group to be alkylated. The said borates and boronates are thus useful in a process for the asymmetric alkylation of a carbonyl group in a compound containing a carbonyl group and an anchor group capable of reacting with a boric or boronic acid derivative. The asymmetric alkylation can be carried out by admixing the compound containing a carbonyl group to be alkylated and the anchor group capable of reacting with a boric or boronic acid derivative with a boric or boronic acid derivative, adding a chiral alcohol, and adding an organometallic compound. After the alkylation reaction, the borate and boronate can be easily removed by hydrolysis.
Patent EA-015022-B1 (EA)
Title: Single use self-disabling syringe
Inventor: LIN ZOU QUAN
IPC: A61M5/32
Filed: 2007-08-14
Abstract: A single use self-disabling syringe is disclosed, which includes a barrel (1), a plunger (2), and a rubber seal (3). At the end of the barrel there is a needle set (4). The front end the plunger (2) has a clip (6), which can completely block the needle set (4). The syringe has the said needle set (4) and barrel (1) as a one-piece moulded, integrated unit. The said barrel (1) has one supporting body (5) at the front end, the supporting body (5) and the inside wall of barrel (1) fitting tightly. The said supporting body (5) has a flexible hook (512) on its top. The said clip (6) and the hook (512) have corresponding cone steps (611) to make sure they match and seal.
Patent EA-015798-B1 (EA)
Title: Baler plunger drive system
Inventor: VU THOMAS H
IPC: A01F15/04
Filed: 2009-12-24
Abstract: A baler for making parallelepiped bales includes a planetary gear drive arrangement including a planet carrier coupled through an overrunning clutch for driving an output shaft which extends cross wise to a forward end of an elongate baling chamber. A plunger is mounted for reciprocating within the baling chamber for compressing crop into a bale, with a crank shaft arrangement being mounted for rotation with the output shaft and being coupled to the plunger by a connecting rod arrangement. When the gear drive arrangement is operating for effecting a compression stroke of the plunger, the overrunning clutch operates in a driving mode. When the gear drive arrangement is operating for effecting a reverse stroke of the plunger, the overrunning clutch operates in an overrunning mode so long as compressed crop is exerting a force on the plunger.
Patent EA-018558-B1 (EA)
Title: Process and plant for removal of carbon dioxide from a feed gas
Inventor: FIND RASMUS
IPC: C01B32/50
Filed: 2008-10-13
Abstract: The present invention relates to a new process for removal of carbon dioxide from a feed gas, wherein the feed gas is fed to and concentrated in a stripper column (A) before condensation of the gaseous carbon dioxide. The present invention also relates to different uses of the removed carbon dioxide and to a plant for removal of carbon dioxide from the feed gas.
Patent EA-016771-B1 (EA)
Title: Climatic equipment control unit, system and method
Inventor: IVANOV SERGEY DIODOROVICH
IPC: G05B19/00
Filed: 2011-07-29
Abstract: The invention pertains to air conditioning, namely, to controlling devices - controllers - to be used in ambient temperature monitoring and control systems, such as heating, ventilation and air conditioning systems with 100% backup required. The invention can be used to control two or more executive units, such as heating/cooling modules, residential and semi-commercial air conditioning systems, ventilation systems (equipped with integrated local master controllers). The suggested technical solution allows to ensure even wear out of equipment in order to provide maximum duration of trouble-free operation of executive units.
Patent EA-022856-B1 (EA)
Title: Utility scale osmotic grid storage
Inventor: MCGINNIS ROBERT
IPC: F03G7/00
Filed: 2009-12-03
Abstract: Systems and methods for the storage of potential energy that may be readily converted to electrical power delivered to a customer or grid distribution are disclosed. This method may involve the use of salinity gradients, or as they may be also described, osmotic pressure gradients or differences between two solutions, to produce hydraulic pressure in a concentrated solution, allowing for the generation of power.
Patent EA-018894-B1 (EA)
Title: N,n-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide used as glucokinase activator and pharmaceutical composition containing same
Inventor: LING ANTHONY LAI
IPC: A61K31/497
Filed: 2010-03-04
Abstract: The present invention provides compounds of Formula (I)that act as glucokinase activators; pharmaceutical compositions thereof.
Patent EA-022068-B1 (EA)
Title: Parasiticidal compositions comprising multiple active agents, methods and uses thereof
Inventor: ROSENTEL JR JOSEPH K
IPC: A61P33/00
Filed: 2011-04-01
Abstract: This invention relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole, at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. This invention also provides for an improved method for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.
Patent EA-025866-B1 (EA)
Title: Smoking article with heat resistant sheet material
Inventor: POGET LAURENT
IPC: A24D1/22
Filed: 2011-03-28
Abstract: A smoking article includes a sheet material (10) comprising a fibrous layer (12) formed of cellulosic fibres and at least 50% by weight of inorganic filler material having a particle size in range of from 0.1 and 50 microns, wherein the sheet material has a tensile strength of at least 900 N/m. The fibrous layer (12) preferably further comprises a binder material, preferably an organic binder material such as a cellulosic binder material. A coating layer (16) may be provided on at least one side of the fibrous layer (12).
Patent EA-024764-B1 (EA)
Title: Cooling tank for rails
Inventor: ANDREATTA DANIELE
IPC: F27D99/00
Filed: 2012-11-12
Abstract: A cooling tank for the thermal treatment of a rail head provided with a structure comprising a first volume (2), adapted to be filled with a cooling fluid; a second volume (4), arranged above the first volume and communicating therewith, so that the fluid passes from the first to the second volume and the rail head to be thermally treated can be immersed therein; a partition plate (5) between first and second volume, provided with a single row of holes (6), preferably arranged at the center of the width of the second volume, for generating jets of cooling fluid from the first to the second volume; a pair of longitudinal bulkheads (7), arranged in said second volume perpendicular to the plate and symmetrically with respect to the single row of holes, adapted to direct the jets of fluid exiting from the holes vertically upwards.
Patent EA-024713-B1 (EA)
Title: Method for determination of reservoir pressure
Inventor: ALIEV TELMAN ABBAS OGLY
IPC: E21B47/06
Filed: 2014-04-09
Abstract: The invention relates to petroleum industry and can be used for determination of reservoir pressure at oil, gas and gas-condensate fields (deposits). The essence of the invention consists in a method for determination of reservoir pressure. The method comprises shutdown of the oil well operated in a stationary mode with known characteristics, recording the change in the bottom-hole pressure, and processing of the pressure build-up curve (PBC) produced in the transient mode of reservoir fluid filtration. The characteristic time T is determined, and the predicted value of reservoir pressure is calculated by the following formula:. Additionally, prior to the well shutdown, the temperature t in the well bottom is measured for more accurate determination of T, and a fluid sample is taken at the flowout line for determining oil viscosity at various t values, where P(0), P(t) are, respectively, the bottomhole pressure before the well shutdown and the current bottomhole pressure, atm; t is time, hours; T is constant characteristic pressure buildup time; ΔP=P(∞)-P(0); at t=∞ P(t)=P.
Patent EA-026703-B1 (EA)
Title: Riboflavin-comprising ophthalmic composition delivered by iontophoresis, useful for the treatment of keratoconus
Inventor: FOSCHINI FULVIO
IPC: A61K31/525
Filed: 2012-10-24
Abstract: The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus. The pH of the composition is between 6.9 and 7.2, and the value of osmolarity is between 90 and 100 mOsm/l, and the following formulation: riboflavin sodium phosphate - 0.147 g, sodium-EDTA - 0.1 g, tris-(hydroxymethyl)aminomethane - 0.05 g, NaHPO∙2HO - 0.385 g, NaHPO∙2HO - 0.217 g, distilled water - up to 100 g.
Patent EA-039584-B1 (EA)
Title: Vibratory screen machine (embodiments) and screen module therefor (embodiments of the module)
Inventor: WOJCIECHOWSKI KEITH F
IPC: B07B1/40
Filed: 2008-02-27
Abstract: According to one embodiment, a vibratory screen machine comprises a screen module (20) having a side member (28); and a compression module (22), wherein the compression module (22) is configured to exert a compression force on the side member (28) and to deform a top surface (110) of the screen module (20) into a concave shape.
Patent EA-030285-B1 (EA)
Title: Apparatus and method for processing open-mouth bags
Inventor: VOLLENKEMPER WILHELM
IPC: B65B43/60
Filed: 2013-11-13
Abstract: Apparatus and method for processing open-mouth bags described in the invention comprise a handling device for exchanging open-mouth bags with a rotary packaging machine. The handling device comprises a rotating device that circulates around a rotation axis of the handling device and is provided with two gripping arms for gripping the open-mouth bags. The two gripping arms are disposed for separate, longitudinal movement transverse to the rotation axis of the rotating device to enable longitudinal movement of the gripping arms relative to the rotating device in addition to the circulating motion around the handling device.
Patent EA-032062-B1 (EA)
Title: Heat-resistant synthetic jewellery material
Inventor: DYMSHITS OLGA SERGEEVNA
IPC: C03C10/12
Filed: 2013-06-25
Abstract: The invention can be used in the chemical industry. Provided is a heat-resistant synthetic jewellery material having a composite nanocrystalline material comprising nanosized oxide and silicate crystalline phases and including at least one crystalline phase selected from the group consisting of spinel, quartz-like phases, sapphirine, enstatite, petalite-like phase, cordierite, willemite, zircon, magnesium aluminotitanates, rutile, zirconium titanate and zirconium dioxide with a content of ions of transition elements, rare-earth elements and precious metals of from 0.001 to 4 mol.%, wherein one of the crystalline phases additionally comprises solid solutions of lithium magnesium zinc aluminosilicates with a virgilite structure, and the composition of the composite nanocrystalline material is selected from the following components, mol.%: SiO- 45-72; AlO- 15-30; MgO - 0.1-23.9; ZnO - 0.1-29; LiO - 1-18; PbO - 0.1-7.0; ZrO- 0.1-10; TiO- 0.1-15; NiO - 0.001-4.0; CoO - 0.001-3.0; CuO - 0.001-4.0; CrO- 0.001-1.0; BiO- 0.001-3.0; FeO- 0.001-3.0; MnO- 0.001-3.0; CeO- 0.001-3.0; NdO- 0.001-3.0; ErO- 0.001-3.0; PrO- 0.001-3.0; Au - 0.001-1.0. The invention makes it possible to produce a transparent, translucent or opaque jewellery material with a low coefficient of thermal expansion and a high degree of heat resistance.
Patent EA-027909-B1 (EA)
Title: Imidazopyridine compounds
Inventor: KUROSAKI TOSHIO
IPC: C07D471/04
Filed: 2013-11-28
Abstract: A pharmaceutical composition for treating or preventing various cardiovascular diseases, which has sGC activities based on improvement of cGMP signals, is provided. It was found that imidazo[1,2-a]pyridine compounds having a carbamoyl group at the 3-position and a particular cyclic group at the 8-position via a methyleneoxy group, or salts thereof have sGC activation, and are useful as active ingredients of pharmaceutical compositions for treating or preventing various sGC-related cardiovascular diseases, in particular, peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension, thereby completing the present invention.
Patent EA-030052-B1 (EA)
Title: Biocidal systems and methods of use thereof
Inventor: CAMPBELL SCOTT
IPC: C09K8/60
Filed: 2014-04-04
Abstract: Systems and methods for controlling microbial growth and/or activity in a gas field fluid or oil field fluid are provided, comprising: a) adding a first biocide component to the gas field fluid or oil field fluid in an amount effective to control microbial growth and/or activity; and b) after a delay, adding a second biocide component to the gas field fluid or oil field fluid.
Patent EA-035319-B1 (EA)
Title: STABILIZATION OF Fc-CONTAINING POLYPEPTIDES
Inventor: KANNAN GUNASEKARAN
IPC: C07K16/00
Filed: 2014-07-30
Abstract: This invention provides polypeptides comprising an antibody Fc region having a deletion of at least one cysteine residue in the hinge region and substitution with a sulfhydryl-containing residue of at least one CH3-interface amino acid. Also provided are Fc-fusion proteins and antibodies containing said polypeptides, nucleic acids and vectors encoding said polypeptides, along with host cells and methods for making said polypeptides.
Patent EA-035779-B1 (EA)
Title: Improved coating system, use thereof for coating components and thus coated components for agricultural and construction machines
Inventor: WEHNER JOCHEN
IPC: C08F222/14
Filed: 2016-04-20
Abstract: The invention relates to a coating material for producing a coating, comprising 10 to 70 wt.% of one or more CH acidic compounds A, 4 to 40 wt.% of one or more vinylogous carbonyl compounds B, 1.5 to 15 wt.% of one or more latent-basic catalysts C, up to 10 wt.% of one or more light stabilizers, up to 20 wt.% of one or more open time extenders, up to 20 wt.% of one or more pot life extenders, up to 70 wt.% of one or more inorganic and/or organic pigments, and 0.1 to 40 wt.% of one or more corrosion protection agents, in all cases based on the total amount of the coating material. The invention also relates to the use of this coating material for producing a topcoat and to a method for applying a coating and to components for agricultural and construction machines coated with such coating.
Patent ES-2168204-B1 (ES)
Title: Procedimiento cuantico para distribuir claves criptograficas sin descartar datos.
Inventor: CABELLO QUINTERO ADAN
IPC: H04L9/08
Filed: 2000-03-21
Granted: 2003-11-01
Abstract: El invento es un procedimiento para distribuir claves criptográficas entre dos usuarios distantes que usan una propiedad de la mecánica cuántica. La novedad de la invención reside en que el número de datos útiles para generar la clave, por cada dato transmitido, es mayor que en cualquier otro procedimiento cuántico de distribución de claves criptográficas previo. El invento se basa en la creación de "enredo" a distancia. El invento simplifica el proceso de comprobación de que la clave no ha sido espiada. En todos los procedimientos cuánticos previos, cualquier intento de espionaje se traduce inevitablemente en que las claves que reciben ambos usuarios dejan de ser iguales. Con la presente invención la acción del espía altera el 75% de la clave, lo que facilita su detección.
Patent ES-2170013-B1 (ES)
Title: Multi-iluminancimetro portatil.
Inventor: PEREZ OCON FRANCISCO
IPC: G01J1/02
Filed: 2000-10-19
Granted: 2003-11-16
Abstract: Multi-iluminancímetro portátil que consiste en un sistema capaz de monitorizar y almacenar la iluminancia en las superficies de cualquier ambiente luminoso mediante un ordenador personal. La toma de datos se realiza empleando detectores ópticos, de forma que la variable que se monitoriza es el equivalente fotométrico de la irradiancia producida por fuentes luminosas que emiten en el espectro visible fundamentalmente. El equipo diseñado y construido consta de un sistema formado por unos detectores cuya misión es la de captar la luz y obtener las variaciones que sufre un ambiente luminoso. Se emplean amplificadores que acondicionan la señal para que el sistema de adquisición de datos funcione correctamente. Los valores se convierten en digitales, que al ser capturados por el ordenador personal se pueden representar en pantalla, obtener un registro de dichos valores, almacenarlos y mostrarlos.